Biomarkers for chronic heart failure.

Lainscak, Mitja, von Haehling, Stephan, Springer, Jochen and Anker, Stefan D (2007) Biomarkers for chronic heart failure. Heart Failure Monitor, 5 (3). pp. 77-82. ISSN 1470-8590

Full text not available from this repository.

Abstract

Cardiac biomarkers play an important role in and provide better pathophysiological understanding of chronic heart failure (CHF). Natriuretic peptides, especially B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP), were found to be useful in the diagnostic assessment and prognostic stratification of patients with CHF. However, they fail to fulfill all the criteria of an ideal biomarker. Currently, we still do not have a single biomarker or a combination of biomarkers to answer all the clinically relevant questions in CHF. Consequently, some widely available biomarkers might have been overlooked in the field of heart failure. This review discusses several biomarkers, and speculates on the possible roles of combining two or more of them. In this respect, hemoglobin, cholesterol, uric acid, and recently identified proteins may prove to be relevant to the field of CHF. Lastly, we anticipate the potential of biomarkers in a variety of chronic diseases with similar pathophysiology.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Rhiannon Harvey
Date Deposited: 09 Jun 2011 16:00
Last Modified: 21 Apr 2020 19:26
URI: https://ueaeprints.uea.ac.uk/id/eprint/32184
DOI:

Actions (login required)

View Item View Item